Brief: China Regenerative Medicine International Appoints Qiu Bin As Exec Director
20/05/2020 16:07
May 20 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* CHINA REGENERATIVE MEDICINE INTERNATIONAL LTD- QIU BIN
APPOINTED
AS AN EXECUTIVE DIRECTOR
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital